Human Tissue Factor (F3) activation kit by CRISPRa
CAT#: GA101499
F3 CRISPRa kit - CRISPR gene activation of human coagulation factor III, tissue factor
CNY 12,255.00
CNY 2,400.00
CNY 3,990.00
Specifications
Product Data | |
Format | 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug) |
Symbol | F3 |
Locus ID | 2152 |
Kit Components | GA101499G1, Tissue Factor gRNA vector 1 in pCas-Guide-GFP-CRISPRa GA101499G2, Tissue Factor gRNA vector 2 in pCas-Guide-GFP-CRISPRa GA101499G3, Tissue Factor gRNA vector 3 in pCas-Guide-GFP-CRISPRa 1 CRISPRa-Enhancer vector, SKU GE100056 1 CRISPRa scramble vector, SKU GE100077 |
Disclaimer | These products are manufactured and supplied by OriGene under license from ERS. The kit is designed based on the best knowledge of CRISPRa SAM technology. The efficiency of the activation can be affected by many factors, including nucleosome occupancy status, chromatin structure and the gene expression level of the target, etc. |
Reference Data | |
RefSeq | NM_001178096, NM_001993 |
Synonyms | CD142; TF; TFA |
Summary | This gene encodes coagulation factor III which is a cell surface glycoprotein. This factor enables cells to initiate the blood coagulation cascades, and it functions as the high-affinity receptor for the coagulation factor VII. The resulting complex provides a catalytic event that is responsible for initiation of the coagulation protease cascades by specific limited proteolysis. Unlike the other cofactors of these protease cascades, which circulate as nonfunctional precursors, this factor is a potent initiator that is fully functional when expressed on cell surfaces, for example, on monocytes. There are 3 distinct domains of this factor: extracellular, transmembrane, and cytoplasmic. Platelets and monocytes have been shown to express this coagulation factor under procoagulatory and proinflammatory stimuli, and a major role in HIV-associated coagulopathy has been described. Platelet-dependent monocyte expression of coagulation factor III has been described to be associated with Coronavirus Disease 2019 (COVID-19) severity and mortality. This protein is the only one in the coagulation pathway for which a congenital deficiency has not been described. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Aug 2020] |
Documents
Resources
基因表达相关资源 |
Other Versions
SKU | Description | Size | Price |
---|---|---|---|
KN203142 | F3 - human gene knockout kit via CRISPR, HDR mediated |
CNY 12,260.00 |
|
KN203142BN | F3 - human gene knockout kit via CRISPR, HDR mediated |
CNY 12,260.00 |
|
KN203142LP | F3 - human gene knockout kit via CRISPR, HDR mediated |
CNY 12,260.00 |
|
KN203142RB | F3 - human gene knockout kit via CRISPR, HDR mediated |
CNY 12,260.00 |
|
KN403142 | F3 - KN2.0, Human gene knockout kit via CRISPR, non-homology mediated. |
CNY 8,680.00 |